An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

High cholesterol is a major driver of heart disease. Statins, like Lipitor and Zocor, emerged as powerful antidotes starting in the 1980s. With blood-pressure medicines, antismoking campaigns and ...

The single dose treatment helped patients lower “bad” cholesterol and triglyerides, both linked to heart disease ...